Chong‐De Lu
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Hepatology 11
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Surgery 5
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
- Co-authors
- Xiaohui Fu (4 shared papers)Shuqun Cheng (9 shared papers)Wei‐Xing Guo (5 shared papers)Wan Yee Lau (7 shared papers)Xiaoping Yao (3 shared papers)Jie Xue (4 shared papers)Hui Dong (1 shared paper)Hongwei Zhang (1 shared paper)
In The Last Decade
Chong‐De Lu
17 papers receiving 467 citations
Chong‐De Lu's Hit Papers
Peers
Comparison fields: 5 of 53
- Hepatology 189
- Cancer Research 112
- Surgery 94
- Oncology 56
- Pathology and Forensic Medicine 30
Countries citing papers authored by Chong‐De Lu
This map shows the geographic impact of Chong‐De Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong‐De Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong‐De Lu more than expected).
Fields of papers citing papers by Chong‐De Lu
This network shows the impact of papers produced by Chong‐De Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong‐De Lu. The network helps show where Chong‐De Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chong‐De Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 139 | |
| 2 | Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial Hit paper breakdown → | 2024 | 91 |
| 3 | 2013 | 64 | |
| 4 | 2013 | 47 | |
| 5 | 2010 | 24 | |
| 6 | 2014 | 22 | |
| 7 | 2021 | 19 | |
| 8 | 2015 | 17 | |
| 9 | 2020 | 14 | |
| 10 | 2019 | 10 | |
| 11 | 2023 | 10 | |
| 12 | 2024 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2020 | 3 | |
| 15 | 2024 | 1 | |
| 16 | 2009 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2026 | 0 |
About Chong‐De Lu
Chong‐De Lu is a scholar working on Hepatology, Surgery, Cancer Research, Pathology and Forensic Medicine and Epidemiology, having authored 18 papers that have together received 476 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer Mechanisms and Therapy (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Phytochemical compounds biological activities (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Natural product bioactivities and synthesis (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Hepatology (189 citations), Cancer Research (112 citations), Surgery (94 citations), Oncology (56 citations) and Pathology and Forensic Medicine (30 citations). Chong‐De Lu has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Xiaohui Fu, Shuqun Cheng, Wei‐Xing Guo, Wan Yee Lau, Xiaoping Yao, Jie Xue, Hui Dong, Hongwei Zhang, Shupeng Liu and Nan Li. Their work appears in journals such as The Oncologist, European Journal of Gastroenterology & Hepatology, Nature Medicine, Journal of Surgical Research and World Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.